# Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference Product

> **NCT05158192** · PHASE1 · COMPLETED · sponsor: **Laboratorios Andromaco S.A.** · enrollment: 12 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Diosmin/Hesperidin (90/10) 500 mg Test Drug
- **DRUG:** Diosmin/Hesperidin (90/10) 500 mg Reference Product

## Key facts

- **NCT ID:** NCT05158192
- **Lead sponsor:** Laboratorios Andromaco S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-04
- **Primary completion:** 2021-12-14
- **Final completion:** 2021-12-14
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05158192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05158192, "Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference Product". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05158192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*